23. November 2010Roche obtains license for EGFR lung cancer assays and will develop Tarceva companion diagnostic testRoche announced that it has obtained a worldwide sublicense from Genzyme Corporation to develop a diagnostic assay for the detection of Epidermal Growth-Factor Receptor (EGFR) mutations.more 25. October 2010Roche receives FDA approval for a second-generation hepatitis C viral load testRoche announced that the FDA has approved the real-time PCR COBAS® TaqMan® HCV Test, v2.0.more 11. October 2010Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical CancerRoche Molecular Systems and the German Cancer Research Center (DKFZ) announced a research collaboration to enable more specific prediction of the risk for developing cervical cancer.more 04. October 2010First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma ProductsRoche announced that the cobas® TaqScreen DPX Test for use on the cobas s 201 system is now available with the CE Mark. It is the first IVD test to offer complete coverage of all human genotypes of parvovirus B19 and hepatitis A virus in one assay. more 22. September 2010Roche receives FDA approval for second-generation hepatitis B viral load testRoche Molecular Diagnostics announced today that the FDA has approved the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for use in the United States. more 12. July 2010Roche obtains co-exclusive license to develop PCR assays detecting mutations in the PI3K oncogeneRoche announced that the company has obtained a worldwide co-exclusive license for the biomarker PI3K from QIAGEN to develop real-time and endpoint PCR diagnostic assays. more 08. July 2010A New Study Shows that Testing for HPV Genotypes 16 and 18 Detects Cervical Pre-Cancer Missed by Pap TestData from the ATHENA U.S. registration trial of over 47,000 women demonstrate that two human papillomavirus genotypes can identify those women with cervical pre-cancer missed by cytologic examination with a Pap test.more 08. July 2010FDA clears Roche’s LightCycler® MRSA Advanced Test for use in the U.S.Roche Molecular Systems announced that the FDA cleared its new LightCycler® MRSA Advanced Test for the detection of MRSA for clinical use in the United States.more 04. June 2010FDA Approves New Roche Dual-PCR Target HIV-1 TestRoche Molecular Diagnostics announced that the Food and Drug Administration approved its new dual-PCR target HIV-1 viral load test...more 26. May 2010QIAGEN and Roche settle dispute over distribution agreement for TheraScreen companion diagnosticsQIAGEN N.V. announced that it has signed an agreement with Roche Molecular Systems Inc. ...more 06. May 2010Roche Introduces New Health Canada Approved Automated Clinical Laboratory System for Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeaeRoche Diagnostics Canada announced the launch of a new Health Canada approved clinical laboratory system designed to increase laboratory testing efficiency and to accommodate current and long-term molecular diagnostic needs. The cobas® 4800 System ...more 18. February 2010Preliminary Data from Roche ATHENA Cervical Cancer Trial Support Value of Human Papillomavirus GenotypingRoche Molecular Systems, Inc. announced that preliminary data from its ATHENA trial support the importance of screening for human papillomavirus (HPV) genotypes...more 17. February 2010Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene MutationRoche Molecular Systems, Inc. announced a research collaboration with Merck Sharp & Dohme Corp...more |